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A highly selective invivo binding of benzo(a)pyrene to rat lung glutathione S-transferases is demonstrated. 
Benzo(a)pyrene or its metabolites are specifically bound to Ya’ and Yc subunits of rat lung glutathione 
Stransferases. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Benzo(a)pyrene and other polycyclic aromatic 
hydrocarbons are known carcinogens. In rodents, 
benzo(a)pyrene has been demonstrated to produce 
cancer in lung and in other organs [l]. The car- 
cinogenic effect of benzo(a)pyrene and other 
polycyclic aromatic hydrocarbons is primarily due 
to highly toxic metabolites of these compounds 
formed during their metabolism by the enzymes of 
the mixed function oxygenase system [2]. 
Glutathione (GSH) S-transferases (EC 2.5.1.18) 
probably represent one of the major defense 
systems for the detoxification of these compounds 
[3-51. GSH Stransferases can catalyse the con- 
jugation of highly toxic epoxides of polycyclic 
aromatic hydrocarbons to GSH thereby preventing 
their conversion to highly carcinogenic polyols. It 
has been suggested that GSH S-transferases may 
also non-catalytically bind carcinogens and precar- 
cinogens and remove them from circulation [4]. 
Here, we report for the first time that rat lung 
GSH S-transferases bind benzo(a)pyrene or its 
metabolites in vivo and that the binding is highly 
selective to the subunits Ya’ and Yc of lung 
enzymes. 
Male Sprague-Dawley rats (225 f 10 g) used in 
this study were obtained from Timco Harlan 
Sprague Dawley Breeding Laboratories, Houston, 
TX. “C-labelled benzo(a)pyrene was purchased 
from New England Nuclear and non-radiolabelled 
benzo(a)pyrene was purchased from Sigma, St. 
Louis, MO. Sources of other chemicals and an- 
tibodies were the same as in [6]. The protocol for 
purification of rat lung GSH S-transferases was 
similar to that of [6]. GSH S-transferase activity 
was determined by the method of [7]. Radioactivi- 
ty counting was performed in a liquid scintillation 
counter (model LS-230) [S]. 
3. RESULTS AND DISCUSSION 
* To whom correspondence should be addressed 
When the rats were intraperitoneally injected 
with “C-labelled benzo(a)pyrene (total counts per 
min (cpm), 4.7 x 106) dissolved in corn oil (specific 
activity, 4.7 x 10’ counts per mg benzo(a)pyrene), 
a steady increase in the levels of benzo(a)pyrene in 
blood was observed up to 28 h (fig.1). Thirty h 
after injection, the rats were killed and the lungs 
were excised, perfused and washed with 10 mM 
potassium phosphate buffer containing 140 mM 
sodium chloride. Lungs (total wet wt of both 
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Fig. 1. Benzo(a)pyrene levels in blood after injecting r*C- 
labelled benzo(a)pyrene to rats. Blood was drawn from 
tail vein at 4 h intervals. 20,ul blood was spotted on a 
piece of filter paper, dried and radioactivity determined. 
lungs, 1.74 g) were homogenized in a Sorvall om- 
nimixer at 4000 rpm to make a 10% homogenate. 
Aliquots of the homogenate (100 ~1) were used for 
radioactivity determinations. The homogenate was 
centrifuged at 10000 x g for 40 min and the 
radioactivity was determined in the supernatant. 
The supernat~t was dialysed against 22 mM 
potassium phosphate (pH 7.0), and passed over an 
affinity column (0.9 x 10 cm) of epoxy activated 
Sepharose 6-B to which GSH was linked. GSH S- 
transferases were eluted with 5 mM GSH in 
50 mM Tris-HCl buffer, pH 9.6. Upon 
~e~SDS/2-mercaptoethanol-polyacryl~ide- 
slab gel electrophoresis [9] of this preparation only 
3 polypeptide bands corresponding to Ya and Ya’ 
(Mr 22000), Yb (Mr 23 500), Yc (Mr 25000) 
subunits were observed. 
A significant amount of radioactivity was found 
to be associated with the lung tissue after 30 h of 
benoz(a)pyrene injection. Gut of 69620 cpm pre- 
sent in 1 g of lung tissue (wet wt), 44039 cpm were 
recovered in the soluble fraction (table 1). In a 
separate experiment when rats were injected in- 
traperitoneally with 14C-labelied benzo(a)pyrene 
(total cpm, 1.0 x lo”> about 18660 cpm were 
detected in 1 g lung tissue. This indicates a dose 
response interrelationship between benzo(a)pyrene 
injected and the amount bound to lung proteins. 
About 75% of total cpm present in the soluble 
fraction were found in GSH S-transferase fraction 
purified by affinity chromatography (table I). 
Since GSH-affinity columns specifically bind GSH 
S-transferases [6,10], a highly selective binding of 
Table I 
Binding of benzo(a)pyrene with GSH S-transferases in 
rat lung 
Fraction obtained from 1 g Subunit 
of lung tissue structure 
cpm 
Whole homogenate 
loo00 X g supernatant 
Total GSH S-transferases 
obtained by affinity 
chromatography* 
GSH S-transferase Ib 
(pr 8.8) 
GSH S-transferase II 
(~17.2) 
GSH S-transferase III 
(P16.8) 
GSH S-transferase IV 
(~16.0) 
GSH S-tranferase V 
(PI 5.3) 
GSH S-transferase VI 
- 
- 
YclYc 
Ya/Ya’ 
Ya/Yb 
or 
YaiYb’ 
Ya’/Ya’ 
32778 
9398 
7948 
ND 
ND 
ND 
11431 
a Details of the affinity chromatography are described in 
the text. The yield of the enzyme activity during the 
affinity step was 63%. During the affinity 
chromatography the recovery of radioactivity (cpm) in 
absorbed and unabsorbed fractions ranged from 
92-95070 
b Total cpm subjected to isoelectric focusing were 
28407. Details of isoelectric focusing were the same as 
in 161 
14C-labelled benzo(a)pyrene (total cpm 4.7 x 106, 
specific activity 4.7 x 10’ cpm/mg benzo(a)pyrene) was 
injected. The efficiency of the machine ranged from 
85-89% 
benzo(a)pyrene to these enzymes is indicated. The 
binding of benzo(a)pyrene with GSH S- 
transferases was confirmed by gel filtration 
studies. When the affinity pool was subjected to 
Sephadex G-100 gel filtration, coincident peaks of 
GSH S-transferase activity and radioactivity were 
obtained corresponding to an &z& value of about 
47000 (fig.2). The binding of benzo(a)pyrene and 
other xenobiotics to cytosolic receptors present in 
rodent lung, liver, and kidney [11,12] has been 
demonstrated. These receptors have .&& values of 
87~-245~ 1121. A coincident peak of radioac- 
tivity and GSH S-transferase activity correspond- 
ing to an Mr value of 47000 indicates that the 
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Fig.2. Sephadex G-100 gel filtration profile of rat lung 
GSH S-transferases. The enzyme sample having 
5000 cpm was passed through a 1.5 x 90 cm column at 
an upward flow rate of 15 ml/h. 4 ml fractions were 
collected. 
observed binding of benzo(a)pyrene to GSH S- 
transferases in this study is not due to the presence 
of these receptors. These results, therefore, strong- 
ly indicate that upon initial exposure, a major por- 
tion of benzo(a)pyrene or its metabolites present in 
the lung is bound to GSH S-transferases. 
Since rat lung has several forms of GSH 4 
transferases, the binding of benzo(a)pyrene with 
specific enzymes/subunits was studied. We have 
previously [6] demonstrated 6 forms of GSH 4 
transferases in rat lung: I (pZ 8.8), II (pZ 7.2), III 
(pZ 6.8), IV (pZ 6.0), V (pZ 5.3), and VI (pZ 4.8). 
Form I is a dimer of Yc subunits (MI 25000) 
whereas form II is a heterodimer of two different 
subunits, Ya and Ya’ , having similar M, values of 
22000. The subunit structures of forms III, IV, 
and V are not completely understood. However, 
all of these forms have Ya subunits along with 
either Yb or Yb’ (MI 23500) subunits. Form VI is 
a homodimer of Ya’ subunits. We have demon- 
strated that the Ya’ subunit is immunologically 
distinct from Ya subunits [6]. This subunit is ex- 
pressed in the lung but not in liver. To investigate 
the binding of benzo(a)pyrene with individual 
forms of rat lung GSH S-transferases, the purified 
GSH S-transferases were subjected to isoelectric 
focusing. Six peaks of enzyme activity correspond- 
ing to the forms I to VI were observed (fig.3). The 
peaks of radioactivity were associated only with 
the forms I, II, and VI (fig.3, table 1). These 
results indicate that only Ya’ and Yc subunits of 
GSH S-transferase bind benzo(a)pyrene because 
no radioactivity was associated with forms III, IV, 
and V which contain Ya, Yb and Yb’ subunits. Of 
0 
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Fig.3. Isoelectric focusing (IEF) profile of purified rat lung GSH S-transferases. A total of 28407 cpm were present 
in the enzyme sample used for IEF. Experimental details were as in [6]. 
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the two benzo(a)pyrene binding subunits the Ya’ 
appear to have a higher affinity for ben- 
zo(a)pyrene. 
The selective binding of benzo(a)pyrene to Ya’ 
and Yc subunits of lung GSH S-transferases was 
confirmed by immunoaffinity studies. For these 
studies antibodies specific to different constituent 
subunits of rat lung GSH S-transferases were used. 
These antibodies were the same as those used in 
[6]. An aliquot of the affinity pool having total 
GSH S-transferases of lung (prior to electrofocus- 
ing) was passed through a column of CNBr- 
activated Sepharose 4B to which antibodies raised 
against GSH S-transferase VI of rat lung (Ya’Ya’) 
were linked. More than 70% of total radioactivity 
associated with the affinity pool was retained by 
this column. These results indicate that the Ya’ 
subunits present in GSH S-transferase VI 
(Ya’Ya’) and GSH S-transferase II (YaYa’) ac- 
count for the binding of about three fourths of the 
total benzo(a)pyrene bound to lung GSH S- 
transferases. When an immunoaffinity column of 
antibodies against Yc subunits was used, only 
about 20% of total radioactivity was retained by 
the column. Immunoaffinity columns of an- 
tibodies raised against a mixture of GSH S- 
transferases III, IV, and V (Ya, Yb and Yb’ 
subunits) did not retain any radioactivity. This fur- 
ther indicated that the subunits Ya, Yb, and Yb’ 
of lung GSH S-transferases do not bind ben- 
zo(a)pyrene. The results of immunoaffinity 
chromatography indicate a highly specific binding 
to Ya’ and Yc subunits. High affinity of the Ya’ 
subunit for benzo(a)pyrene binding indicates that 
this subunit may play an important noncatalytic 
role in the protection of lung tissue against 
chemically induced carcinogenesis. However, the 
metabolic fate of benzo(a)pyrene-enzyme com- 
plex and whether or not this complex is 
translocated to nucleus should be studied before 
assigning a definitive protective role to these en- 
zymes. We have shown previously that the Ya’ 
subunit is present in lung but not in liver. Selective 
expression of Ya’ subunit in lung may have ev- 
olved to meet the special detoxication needs of this 
tissue. In case human lung GSH Stransferases also 
bind benzo(a)pyrene the noncatalytic role of these 
enzymes may be very important in the detoxication 
of polycyclic aromatic hydrocarbons present in air 
as pollutants. 
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